Grayscale ultrasound radiomics for characterizing subpleural pulmonary lesions: a multicenter prospective study.
OpenAlex 토픽 ·
Radiomics and Machine Learning in Medical Imaging
Lung Cancer Diagnosis and Treatment
Ultrasound in Clinical Applications
[OBJECTIVES] To develop and validate a radiomics model based on grayscale ultrasound (GSUS) images for characterizing subpleural pulmonary lesions (SPLs).
- 표본수 (n) 407
- 95% CI 0.828-0.940
APA
Jiawei Yi, Xinyu Zhao, et al. (2026). Grayscale ultrasound radiomics for characterizing subpleural pulmonary lesions: a multicenter prospective study.. Insights into imaging, 17(1). https://doi.org/10.1186/s13244-026-02244-1
MLA
Jiawei Yi, et al.. "Grayscale ultrasound radiomics for characterizing subpleural pulmonary lesions: a multicenter prospective study.." Insights into imaging, vol. 17, no. 1, 2026.
PMID
42034838
Abstract
[OBJECTIVES] To develop and validate a radiomics model based on grayscale ultrasound (GSUS) images for characterizing subpleural pulmonary lesions (SPLs).
[MATERIALS AND METHODS] In this prospective, multicenter study, 738 patients with CT-confirmed SPLs were enrolled from three institutions and assigned to training (n = 407), internal validation (n = 146), and external validation (n = 185) cohorts. A total of 1320 radiomics features were extracted from both lesion and perilesional regions on GSUS images. Feature selection was performed through intra- and inter-class correlation coefficients (ICCs) analyses, Pearson correlation analyses, and least absolute shrinkage and selection operator (LASSO) regression. Clinical-radiomics fusion models were subsequently constructed by integrating selected radiomics features with key clinical variables using multivariate logistic regression. Model performance was evaluated comprehensively using the area under the receiver-operating characteristic curve (AUC), sensitivity, specificity, F1-score, and additional diagnostic metrics.
[RESULTS] Five predictive models were constructed based on clinical, radiologic, and radiomics features. Among them, the integrated model combining lesion-based radiomics with clinical variables achieved the best diagnostic performance, with AUCs of 0.884 (95% CI: 0.828-0.940) in the internal validation cohort and 0.848 (95% CI: 0.791-0.904) in the external validation cohort. Calibration and decision curve analyses demonstrated good model calibration and favorable clinical utility. The diagnostic accuracy of the model was comparable to that of experienced lung ultrasound radiologists.
[CONCLUSIONS] The GSUS-based radiomics model effectively differentiates between benign and malignant SPLs, demonstrating strong diagnostic performance and promising clinical applicability.
[CRITICAL RELEVANCE STATEMENT] The proposed ultrasound-based radiomics model provides a reproducible, noninvasive decision-support tool for characterizing subpleural pulmonary lesions, offering particular value in patients for whom invasive procedures are unsuitable or in settings where CT or biopsy is not readily available.
[KEY POINTS] Accurate characterization of subpleural pulmonary lesions remains challenging using conventional imaging techniques. The grayscale ultrasound radiomics model achieved accuracy comparable to expert radiologists. This model provides a noninvasive and accessible tool when CT or biopsy is limited.
[MATERIALS AND METHODS] In this prospective, multicenter study, 738 patients with CT-confirmed SPLs were enrolled from three institutions and assigned to training (n = 407), internal validation (n = 146), and external validation (n = 185) cohorts. A total of 1320 radiomics features were extracted from both lesion and perilesional regions on GSUS images. Feature selection was performed through intra- and inter-class correlation coefficients (ICCs) analyses, Pearson correlation analyses, and least absolute shrinkage and selection operator (LASSO) regression. Clinical-radiomics fusion models were subsequently constructed by integrating selected radiomics features with key clinical variables using multivariate logistic regression. Model performance was evaluated comprehensively using the area under the receiver-operating characteristic curve (AUC), sensitivity, specificity, F1-score, and additional diagnostic metrics.
[RESULTS] Five predictive models were constructed based on clinical, radiologic, and radiomics features. Among them, the integrated model combining lesion-based radiomics with clinical variables achieved the best diagnostic performance, with AUCs of 0.884 (95% CI: 0.828-0.940) in the internal validation cohort and 0.848 (95% CI: 0.791-0.904) in the external validation cohort. Calibration and decision curve analyses demonstrated good model calibration and favorable clinical utility. The diagnostic accuracy of the model was comparable to that of experienced lung ultrasound radiologists.
[CONCLUSIONS] The GSUS-based radiomics model effectively differentiates between benign and malignant SPLs, demonstrating strong diagnostic performance and promising clinical applicability.
[CRITICAL RELEVANCE STATEMENT] The proposed ultrasound-based radiomics model provides a reproducible, noninvasive decision-support tool for characterizing subpleural pulmonary lesions, offering particular value in patients for whom invasive procedures are unsuitable or in settings where CT or biopsy is not readily available.
[KEY POINTS] Accurate characterization of subpleural pulmonary lesions remains challenging using conventional imaging techniques. The grayscale ultrasound radiomics model achieved accuracy comparable to expert radiologists. This model provides a noninvasive and accessible tool when CT or biopsy is limited.
같은 제1저자의 인용 많은 논문 (4)
- Seroprevalence and Epidemiological Characteristics of Severe Fever with Thrombocytopenia Syndrome in Patients with Chronic Diseases in Korea.
- Influence of diabetes on survival of patients with glioma: a meta-analysis.
- Exploring novel strategies of oncolytic viruses and gut microbiota to enhance CAR-T cell therapy for colorectal cancer.
- EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p.